GO:0060980 cell migration involved in coronary vasculogenesis: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0060980 describes the directed movement of cells that contributes to the formation of endothelial cells lining the heart's blood vessels.
This process is essential for coronary artery development; defects are linked to congenital heart disease and impaired cardiac repair.
Key molecular players include LIM kinases, cadherins, NADPH oxidases, and endothelial progenitor cells.
Monocytes and endothelial progenitor cells are recruited to the developing coronary vasculature and contribute to vessel formation.
Reactive oxygen species (ROS) and NADPH oxidase signaling regulate the migratory behavior of endothelial progenitors.
CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in coronary vasculogenesis.

Description

Coronary vasculogenesis is the developmental process by which the heart establishes its own blood supply. GO:0060980, cell migration involved in coronary vasculogenesis, captures the directed movement of cells that will differentiate into endothelial cells forming the heart's blood vessels. This ontology term is critical for understanding how progenitor cells navigate to the developing heart and assemble into functional coronary vessels. Disruption of this migration process is associated with congenital coronary anomalies and impaired cardiac repair after injury. Researchers studying cardiovascular development, regenerative medicine, and angiogenesis rely on this term to annotate gene functions and interpret transcriptomic or imaging data. The process involves coordinated signaling through LIM kinases, cadherins, NADPH oxidase, and chemokine gradients that guide endothelial progenitors to the coronary plexus.

cell migration involved in coronary vasculogenesis At A Glance

GO ID GO:0060980
GO term cell migration involved in coronary vasculogenesis
Ontology biological_process
Synonym None
Major function Directed movement of progenitor cells that differentiate into coronary endothelial cells
Related processes Angiogenesis, vasculogenesis, endothelial cell differentiation, cell motility
Key regulators LIM kinases, cadherins, NADPH oxidase, chemokines
Disease relevance Congenital heart defects, coronary artery disease, impaired cardiac repair

What Is GO:0060980?

GO:0060980 is defined as the orderly movement of a cell from one site to another that will contribute to the differentiation of an endothelial cell that will form the blood vessels of the heart. In other words, it is the directed migration step that precedes and enables the formation of coronary endothelial cells, ensuring that progenitor cells reach the correct anatomical location to build the coronary vasculature.

Why Is cell migration involved in coronary vasculogenesis Important in Cell Biology?

Understanding GO:0060980 is essential because coronary vasculogenesis is a prerequisite for normal heart development and function. Defects in the migration of endothelial progenitors can lead to congenital coronary anomalies, myocardial ischemia, and poor recovery after cardiac injury. Moreover, the molecular mechanisms governing this migration, such as LIM kinase-mediated actin dynamics and cadherin-based adhesion, are shared with pathological angiogenesis in cancer and atherosclerosis. Therefore, studying this process provides insights into both developmental biology and disease pathogenesis, and it offers potential targets for therapeutic revascularization.
Required for establishing the coronary circulation during embryogenesis.
Dysregulation leads to congenital heart defects and coronary artery anomalies.
Shares molecular machinery with tumor angiogenesis and atherosclerosis.
Involves endothelial progenitor cells that can be harnessed for regenerative therapies.
ROS and NADPH oxidase signaling modulate migratory capacity of endothelial cells.
LIM kinases regulate actin cytoskeleton dynamics necessary for cell motility.
Cadherins mediate cell-cell adhesion critical for coordinated migration.
Monocytes contribute to angiogenesis by releasing pro-migratory factors.
Peptide Lv promotes pathological angiogenesis, highlighting migratory pathways.
Tissular insemination of progenitor endothelial cells is a proposed therapeutic strategy.

What Happens During cell migration involved in coronary vasculogenesis?

Initiation and Chemoattraction
In simple terms: Cells receive signals that tell them where to go.
The process begins when progenitor cells respond to chemotactic cues that guide them toward the developing heart. Monocytes and endothelial progenitor cells are recruited by factors such as vascular endothelial growth factor and stromal cell-derived factor-1, which activate migratory signaling pathways. NADPH oxidase-derived reactive oxygen species (ROS) also act as chemoattractant signals, promoting directional migration.
Cytoskeletal Rearrangement and Motility
In simple terms: The cell's internal skeleton changes shape to allow movement.
Upon stimulation, LIM kinases phosphorylate cofilin, leading to actin filament stabilization and reorganization that drives cell protrusion and forward movement. Cadherins mediate dynamic cell-cell adhesions that coordinate collective migration and maintain tissue integrity during coronary vessel formation.
Adhesion and Matrix Remodeling
In simple terms: Cells stick to and reshape their surroundings to move through tissue.
Migrating cells interact with the extracellular matrix via integrins and secrete proteases to remodel the matrix, creating paths for migration. Cadherin-mediated junctions are continuously formed and broken to allow movement while keeping cells connected. This remodeling is essential for the progenitor cells to reach the coronary plexus.
Differentiation into Coronary Endothelial Cells
In simple terms: Once they arrive, the cells become blood vessel lining cells.
After reaching the target site, the migrated cells differentiate into endothelial cells that assemble into primitive coronary vessels. This step involves the expression of endothelial markers such as CD31 and VE-cadherin, and is influenced by the local microenvironment. The entire process ensures the heart receives its own blood supply.

Key Genes Involved in GO:0060980 cell migration involved in coronary vasculogenesis

The following genes and proteins have been experimentally implicated in cell migration involved in coronary vasculogenesis or closely related angiogenic processes.
GeneMajor RoleResearch Relevance
LIMK1Phosphorylates cofilin to regulate actin dynamicsKnockout reduces cell motility; target for cardiovascular disease
LIMK2Regulates actin cytoskeleton and cell migrationImplicated in vascular remodeling and angiogenesis
CDH5 (VE-cadherin)Endothelial cell-cell adhesionEssential for vascular integrity and migration
CDH2 (N-cadherin)Cell adhesion and migrationModulates vascular smooth muscle and endothelial behavior
NOX1NADPH oxidase subunit; produces ROSROS-dependent migration and angiogenesis
NOX2 (CYBB)NADPH oxidase subunit; ROS productionRegulates endothelial progenitor cell function
NOX4NADPH oxidase; hydrogen peroxide generationModulates angiogenic signaling
VEGFAChemoattractant and pro-angiogenic factorDrives endothelial progenitor migration
CXCL12 (SDF-1)Chemokine guiding progenitor cellsRecruits endothelial progenitors to ischemic tissue
CXCR4Receptor for CXCL12Mediates homing and migration of progenitors
PECAM1 (CD31)Endothelial cell adhesion moleculeMarker of endothelial differentiation
KDR (VEGFR2)VEGF receptor; promotes migrationKey mediator of angiogenic sprouting
MMP2Matrix metalloproteinase; degrades ECMFacilitates cell migration through matrix
MMP9Matrix metalloproteinase; ECM remodelingInvolved in progenitor cell mobilization
ITGB1 (Integrin beta1)ECM adhesion and signalingRequired for migration on matrix proteins
RAC1Rho GTPase; regulates actin dynamicsControls cell protrusion and migration
RHOARho GTPase; regulates contractilityModulates cell migration and adhesion
CFL1 (Cofilin)Actin depolymerizing factorTarget of LIMK; regulates motility

How Is cell migration involved in coronary vasculogenesis Regulated?

The migration of cells involved in coronary vasculogenesis is tightly regulated by signaling pathways including LIM kinase/cofilin, Rho GTPases, and NADPH oxidase-derived ROS. LIM kinases are activated downstream of Rho-associated kinase (ROCK) and phosphorylate cofilin, thereby stabilizing actin filaments and promoting directional migration. Cadherin-mediated adhesion complexes dynamically regulate cell-cell contacts and cytoskeletal organization, and their expression is modulated by growth factors such as VEGF. ROS produced by NADPH oxidases act as second messengers to activate migratory signaling and are balanced by antioxidant systems. Additionally, chemokine gradients of CXCL12 and VEGF guide progenitor cells to the coronary region, and their receptors are subject to feedback regulation.

cell migration involved in coronary vasculogenesis and Human Disease

GeneDisease / BiologyPotential Experimental Model
LIMK1Congenital heart defects; impaired cell migrationKnockout mouse; point mutation of kinase domain
CDH5Vascular permeability; coronary anomaliesEndothelial-specific knockout; knock-in of mutant cadherin
NOX2Atherosclerosis; ROS-mediated endothelial dysfunctionNOX2 knockout; overexpression of dominant-negative
CXCR4Defective progenitor homing; impaired cardiac repairKnock-in of CXCR4 variants; knockout in endothelial lineage
VEGFAAngiogenesis; coronary vessel developmentInducible overexpression; conditional knockout
Congenital Heart Defects and Coronary Anomalies
Disruption of cell migration involved in coronary vasculogenesis can lead to congenital coronary artery anomalies, including anomalous origin of coronary arteries and coronary fistulas. Studies in animal models show that loss of LIMK1 or cadherin function impairs coronary vessel formation and causes myocardial hypoplasia. These defects highlight the importance of precise migratory control during heart development.
Atherosclerosis and Vascular Disease
Aberrant migration of endothelial progenitor cells and monocytes contributes to atherosclerosis. Monocytes recruited to the vessel wall release pro-angiogenic factors that exacerbate plaque neovascularization, a process dependent on migratory signaling. NADPH oxidase-derived ROS further promote endothelial dysfunction and pathological angiogenesis in lower extremity artery disease.
Cancer and Pathological Angiogenesis
Tumor angiogenesis shares molecular mechanisms with coronary vasculogenesis, including LIM kinase-mediated actin remodeling and cadherin-dependent adhesion. Peptide Lv has been shown to promote pathological angiogenesis, suggesting that migratory pathways are co-opted in cancer. Targeting these pathways may provide therapeutic opportunities.
Cardiac Regeneration and Repair
After myocardial infarction, the migration of endothelial progenitor cells to the injured heart is critical for neovascularization and functional recovery. Enhancing progenitor cell migration through modulation of LIM kinases or ROS signaling is a potential therapeutic strategy. Tissular insemination of progenitor endothelial cells has been proposed as a method to improve cardiac repair.

From cell migration involved in coronary vasculogenesis-Related Genes to Experimental Models

Research QuestionSuitable Model
Does gene X regulate migration of coronary endothelial progenitors?Knockout of gene X in endothelial lineage using Cre-lox
Does a specific point mutation in gene X alter migratory capacity?Point mutation knock-in via CRISPR-Cas9
Does overexpression of gene X enhance coronary vasculogenesis?Transgenic overexpression or viral delivery
Where and when is gene X expressed during coronary development?Tagged knock-in (e.g., GFP) for live imaging
What is the transcriptional response during migration?RNA-seq of sorted progenitor cells
Can gene X rescue migration defects in vitro?Overexpression in primary endothelial cells

How to Study the cell migration involved in coronary vasculogenesis Process

MethodWhat It MeasuresTypical Application
Live imagingCell movement dynamics in real timeVisualizing coronary progenitor migration in embryos
RNA-seqTranscriptional changes during migrationIdentifying genes upregulated in migratory cells
ProteomicsProtein expression and modificationsDetecting LIMK-dependent cofilin phosphorylation
Boyden chamber assayChemotactic migration capacityTesting gene knockout effects on cell motility
Scratch wound assayDirectional migration and wound closureAssessing overexpression or knockdown
CRISPR screenGenome-wide identification of regulatorsDiscovering novel genes in coronary vasculogenesis
ImmunofluorescenceProtein localization and cytoskeletal changesVisualizing actin reorganization during migration
Live Imaging and Lineage Tracing
Live imaging of fluorescently labeled endothelial progenitors in zebrafish or mouse embryos allows direct visualization of cell migration during coronary vasculogenesis. Lineage tracing using Cre-lox systems can identify the origin and fate of migrating cells.
Transcriptomic and Proteomic Profiling
RNA-seq and single-cell RNA-seq of sorted progenitor cells reveal gene expression changes during migration. Proteomics can identify post-translational modifications such as LIMK-mediated cofilin phosphorylation.
In Vitro Migration Assays
Boyden chamber and scratch wound assays measure the migratory capacity of endothelial cells or progenitors under genetic manipulation. These assays are used to test the effect of knockout or overexpression of candidate genes.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens in endothelial progenitor cells can identify novel regulators of migration. Hits are validated in vivo using mouse models of coronary vasculogenesis.

How CRISPR Can Be Used to Study GO:0060980 cell migration involved in coronary vasculogenesis

Knockout

CRISPR-Cas9 knockout of candidate genes such as LIMK1 or CDH5 in endothelial progenitor cells or mouse models can determine whether they are required for cell migration involved in coronary vasculogenesis. Knockout models often show reduced migration and defective coronary vessel formation.

Point Mutation

Introducing specific point mutations (e.g., kinase-dead LIMK1) via CRISPR base editing or homology-directed repair allows precise testing of domain functions in migration. This approach distinguishes catalytic activity from scaffolding roles.

Knock-in

Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci enables live tracking of migrating cells and biochemical analysis of protein complexes. Knock-in of disease-associated variants can model human coronary anomalies.

Overexpression

CRISPR activation (CRISPRa) or transgenic overexpression of pro-migratory genes such as VEGFA or CXCL12 can enhance coronary vasculogenesis and improve cardiac repair after injury. Overexpression models are useful for gain-of-function studies.

How EDITGENE Supports cell migration involved in coronary vasculogenesis Research

Researchers studying cell migration involved in coronary vasculogenesis-related genes often need to determine whether a candidate gene is causally involved in progenitor cell recruitment, differentiation, or vessel assembly. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models and animal models, enabling rigorous functional validation of genes implicated in this process.
Contact EDITGENE today to design your custom CRISPR model for cell migration involved in coronary vasculogenesis research.

Frequently Asked Questions About cell migration involved in coronary vasculogenesis

GO:0060980 is the Gene Ontology term for cell migration involved in coronary vasculogenesis, defined as the orderly movement of a cell that contributes to the differentiation of an endothelial cell forming the heart's blood vessels.
Key genes include LIMK1, LIMK2, CDH5, CDH2, NOX1, NOX2, NOX4, VEGFA, CXCL12, CXCR4, and PECAM1, among others.
It is regulated by LIM kinase/cofilin signaling, Rho GTPases, cadherin-mediated adhesion, and NADPH oxidase-derived ROS, as well as chemokine gradients.
Defects are linked to congenital heart defects, coronary artery anomalies, atherosclerosis, and impaired cardiac repair after myocardial infarction.
Methods include live imaging, lineage tracing, RNA-seq, proteomics, in vitro migration assays, and CRISPR screens.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in endothelial progenitor cells and animal models.
LIM kinases regulate actin cytoskeleton dynamics by phosphorylating cofilin, which is essential for cell motility during coronary vessel formation.
Cadherins mediate cell-cell adhesion and coordinate collective migration of endothelial progenitors, maintaining tissue integrity during vessel formation.
NADPH oxidase produces reactive oxygen species that act as signaling molecules to promote endothelial cell migration and angiogenesis.
Endothelial progenitor cells can be recruited to sites of injury to promote neovascularization; enhancing their migration is a therapeutic goal.

Conclusion

GO:0060980, cell migration involved in coronary vasculogenesis, is a fundamental biological process that ensures the heart develops its own blood supply. Its molecular regulation by LIM kinases, cadherins, and ROS signaling is critical for normal development and is implicated in congenital heart defects, atherosclerosis, and cancer. Continued research using CRISPR-based models will uncover new therapeutic targets for cardiovascular disease.

References

  1. 1. Lateef OM et al.. 2024. LIM kinases in cardiovascular health and disease.. Front Physiol 15:1506356 PMID: 39744707
  2. 2. Frismantiene A et al.. 2018. Cadherins in vascular smooth muscle cell (patho)biology: Quid nos scimus?. Cell Signal 45:23-42 PMID: 29413845
  3. 3. Jaipersad AS et al.. 2014. The role of monocytes in angiogenesis and atherosclerosis.. J Am Coll Cardiol 63(1):1-11 PMID: 24140662
  4. 4. Shi L et al.. 2019. Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.. J Am Heart Assoc 8(22):e013673 PMID: 31698979
  5. 5. Ushio-Fukai M et al.. 2009. Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function.. Antioxid Redox Signal 11(10):2517-33 PMID: 19309262
  6. 6. Khoo CP et al.. 2008. Endothelial progenitor cells and their potential therapeutic applications.. Regen Med 3(6):863-76 PMID: 18947309
  7. 7. Hutchings G et al.. 2021. Molecular Mechanisms Associated with ROS-Dependent Angiogenesis in Lower Extremity Artery Disease.. Antioxidants (Basel) 10(5) PMID: 34066926
  8. 8. Moldovan NI. 2003. Tissular insemination of progenitor endothelial cells: the problem, and a suggested solution.. Adv Exp Med Biol 522:99-113 PMID: 12674214
Contact Us
*
*
*
*
How did you hear about us: